Abulkhair Hamada S
Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt.
Pharmaceutical Chemistry Department, Faculty of Pharmacy, Horus University-Egypt, New Damietta, Egypt.
Arch Pharm (Weinheim). 2025 Jan;358(1):e2400802. doi: 10.1002/ardp.202400802. Epub 2024 Dec 10.
Developing new molecular entities is one of the most emerging research areas in the field of Medicinal Chemistry. Over the past few years, rigorous research has been conducted on sulfaguanidine-linked synthetic molecules because of their promising potential in several biological activities. Sulfaguanidine has been actively incorporated in the design of anticancer, antimicrobial, antidiabetic, antiparkinsonian, anti-inflammatory, and antiviral candidates. The construction of these effective candidates has adopted many chemical approaches. A number of the prepared compounds displayed promising results that merit further investigations for the development of new medications. This review summarizes the different chemical strategies and the reported activities for sulfaguanidine-linked synthetic molecules throughout 2020-2024.
开发新的分子实体是药物化学领域中最热门的研究领域之一。在过去几年里,由于磺胺胍连接的合成分子在多种生物活性方面具有潜在的应用前景,因此对其进行了深入研究。磺胺胍已被积极应用于抗癌、抗菌、抗糖尿病、抗帕金森病、抗炎和抗病毒候选药物的设计中。这些有效候选药物的构建采用了多种化学方法。许多制备的化合物显示出有前景的结果,值得进一步研究以开发新药物。本综述总结了2020年至2024年期间磺胺胍连接的合成分子的不同化学策略和已报道的活性。